Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: J Cardiovasc Transl Res. 2019 Feb 12;12(4):280–289. doi: 10.1007/s12265-019-09866-5

Table 3.

Full logistic regression model including all clinical covariates and ADRB1 Ser49 homozygous status for the primary outcome of LVEF recovery to ≥ 40%.

Variable OR 95% CI *p
ADRB1 Ser49 homozygotes 8.17 2.07 – 32.22 0.003
Age 1.00 0.96 – 1.04 0.991
Female sex 4.07 1.27 – 13.03 0.018
African-American race 1.01 0.29 – 3.51 0.983
Systolic blood pressure 1.03 0.99 – 1.06 0.074
Non-diabetic 0.84 0.28 – 2.51 0.757
aQRS duration 0.98 0.96 – 1.01 0.122
aIschemic etiology 0.93 0.17 – 5.10 0.933
aNYHA functional class 0.69 0.34 – 1.39 0.296

ADRB1 = gene for the beta-1 adrenergic receptor; CI = confidence interval; Gly = glycine; LVEF = left ventricular ejection fraction; OR = odds ratio; SBP = systolic blood pressure; Ser = serine

a.

Mean values were used to impute missing data for n = 32 missing QRS duration, n = 40 missing ischemic etiology, and n = 34 missing NYHA functional class.

*

p-value is for type III analysis of effects; bolded values indicate statistical significance (p < 0.05)